STOCKHOLDERS’ EQUITY (Tables)

3 Months Ended

Mar. 29, 2024

Equity [Abstract]

Schedule of Allocation of Share-Based Compensation Expense

The following table sets forth the detailed allocation of the share-based compensation expense which was included in the Company’s condensed consolidated statements of operations:

	Three Months Ended
(in thousands)	March 29, 2024		March 31, 2023
Cost of revenue	$	523	$	850
Research and development expense	1,955		2,099
Selling, general and administrative expense	4,445		4,475
Total	$	6,923	$	7,424

Schedule of Restricted Stock Units

(in thousands, except per share amounts)	Number of Shares	Weighted Average Grant-Date Fair Value Per Share
Balance at December 31, 2023	3,242	$	12.42
Granted	1,412	13.78
Vested	(1,278)	11.58
Forfeited	(91)	12.36
Balance at March 29, 2024	3,285	$	13.34